|
Association of CHEK2 variants with breast cancer risk |
||||||
| CHEK2 statusa |
Cases (n = 506) |
Controls (n = 459) |
ORb |
95% CI |
||
|
|
||||||
| n |
% |
n |
% |
|||
|
|
||||||
| 1100del C |
||||||
| Noncarrier |
499 |
98.8 |
456 |
99.6 |
1.0 |
Reference |
| Carrier |
6 |
1.2 |
2 |
0.4 |
2.9 |
(0.6–14.6) |
| R145W |
||||||
| Noncarrier |
505 |
99.8 |
459 |
100.0 |
1.0 |
Reference |
| Carrier |
1 |
0.2 |
0 |
- |
- |
- |
| I175T |
||||||
| Noncarrier |
504 |
99.6 |
455 |
99.1 |
1.0 |
Reference |
| Carrier |
2 |
0.4 |
4 |
0.9 |
0.5 |
(0.1–2.6) |
|
aAll carriers are heterozygous. bAdjusted for age at reference and reference year. CI, confidence interval; OR, odds ratio. | ||||||
Friedrichsen et al. Breast Cancer Res 2004 6:R629 doi:10.1186/bcr933 |
||||||